CSI Market
Sign In | Register

Gene Biotherapeutics Inc (CRXM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CRXM Annual Balance Sheets →
The table below presents a historical view of Gene Biotherapeutics Inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
(Sep 30 2020) (Jun 30 2020) (Mar 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent0.39
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.02
Total Current Assets0.41
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.15
Operating Lease Right Of Use Asset0.15
Total Assets0.57
Liabilities
Accounts Payable, Current AC0.75
Accrued Liabilities, Current AC3.13
Notes Payable, Current NO0.56
Other Liabilities, Current0.59
Total Current Liabilities5.03
Long-term debt0.03
Total Long-term Debt0.03
Other liabilities, Noncurrent0.08
Operating Lease Liability Current0.07
Operating Lease Liability Noncurrent0.08
Total Liabilities5.14
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock115.55
Retained Earnings / Accumulated Deficit-119.43
Other Equity0.00
Common Stockholder's Equity-3.88
Non-controlling interests & other-0.69
Total Stockholder's Equity-4.57
Liabilities & Stockholder's Equity0.57
4 historic quarters locked

Sign in to unlock the full Gene Biotherapeutics Inc balance sheet history.

Sign In Create Free Account

About Gene Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form:
  • Filed with the SEC: April 13, 2022

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-22-009863

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License